Landmark study to assess long-term health risks and benefits of prior aspirin use in elderly PRESS RELEASE ...
Participants
Researchers from National Cancer Institute (NCI) visit ASPREE
A welcome to Melbourne Australian ASPREE investigators welcomed members from the National Cancer Institute...
ASPREE publishes trial results in New England Journal of Medicine today!
Daily low-dose aspirin doesn't reduce heart-attack risk in healthy people For decades, doctors have been prescribing...
ASPREE presentations in 2017
Study updates across south-eastern Australia in 2017, more to come From Wollongong to Burnie, members of...
UK aspirin study on GI bleeding
Daily aspirin users might need a PPI Elderly patients taking daily aspirin after a stroke or MI (heart...
ASPREE investigator reflects on public-good clinical trials
Prof Chris Reid shares 30 years experience in medical research Professor Chris Reid is a Director of the Monash...
ASPREE international researcher meet-up
Earlier this month we welcomed our U.S. research collaborators from the Berman Center for Outcomes and Clinical...
NHMRC Funding Boost for Australia’s Largest Clinical Aspirin Trial
Australian Government funding for ASPREE Completion The ASPREE Clinical Trial received more than $5.5 million...
Aspirin overview: history, use, secondary prevention and primary prevention
Weekly Dose: aspirin, the pain and fever reliever that prevents heart attacks, strokes and maybe cancer Aspirin...
Dementia Awareness Month
Reminding people impacted by dementia that they are not alone ASPREE warmly welcomes and thanks Ann...